Lantern Pharma Inc. filed a Form D with the Securities and Exchange Commission on 2026-05-21.
Lantern Pharma Inc. filed a Form D notice of an exempt securities offering with the SEC on May 21, 2026. Its industry group is Pharmaceuticals. It names Panna Sharma (Chief Executive Officer, President), Donald Keyser (Chairman of the Board), David Margrave (Chief Financial Officer, Secretary) (SEC Form D, May 21, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Lantern Pharma Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-05-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Lantern Pharma Inc.
Free to see. No signup.
More on the people and the money behind Lantern Pharma Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Texas, filed within 90 days of this one, largest first.
Get an email when Lantern Pharma Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Lantern Pharma Inc. raises, hires or launches. No email unless you switch it on.
Watch Lantern Pharma Inc. →Get the full cited report on Lantern Pharma Inc.
What the filing shows about Lantern Pharma Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Lantern Pharma Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Lantern Pharma Inc.'s address as 1920 Mckinney Avenue, 7TH Floor, Dallas, TX 75201.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Lantern Pharma Inc. is a registered filer with the SEC (CIK 1763950) and has filed since 2026-05-21. 1 filing is on record, the latest on 2026-05-21.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Lantern Pharma Inc.'s Form D of 2026-05-21 names Panna Sharma, Donald Keyser, David Margrave and 5 more as its officers, directors or promoters.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Lantern Pharma is an oncology-focused clinical stage pharmaceutical company leveraging Artificial Intelligence, Genomics, and Machine Learning to transform the cost, pace, and timeline of drug discovery and development.
The title and description the site itself served, answering 200, after redirecting from https://lanternpharma.com. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director.
Panna Sharma is named as Chief Executive Officer, President on the Form D that Lantern Pharma Inc. filed with the SEC on 21 May 2026, one of 8 people that filing names.
On the filing as: Director.
Donald Keyser is named as Chairman of the Board on the Form D that Lantern Pharma Inc. filed with the SEC on 21 May 2026, one of 8 people that filing names.
On the filing as: Executive Officer.
David Margrave is named as Chief Financial Officer, Secretary on the Form D that Lantern Pharma Inc. filed with the SEC on 21 May 2026, one of 8 people that filing names.
On the filing as: Executive Officer.
Kishor Bhatia is named as Chief Scientific Officer on the Form D that Lantern Pharma Inc. filed with the SEC on 21 May 2026, one of 8 people that filing names.
Vijay Chandru is named as Director on the Form D that Lantern Pharma Inc. filed with the SEC on 21 May 2026, one of 8 people that filing names.
Maria Maccecchini is named as Director on the Form D that Lantern Pharma Inc. filed with the SEC on 21 May 2026, one of 8 people that filing names.
Lee Schalop is named as Director on the Form D that Lantern Pharma Inc. filed with the SEC on 21 May 2026, one of 8 people that filing names.
David Silberstein is named as Director on the Form D that Lantern Pharma Inc. filed with the SEC on 21 May 2026, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role and 5 as directors only.
Named as of the 2026-05-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Lantern Pharma Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Lantern Pharma Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lantern Pharma Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Lantern Pharma Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Lantern Pharma Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (lanternpharma.com).
Each opens in a new tab, filled in for Lantern Pharma Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Dallas-Fort Worth
https://mentionfox.com/funding/lantern-pharma-inc-form-d-26000001